Ad
Monday, 8 June 2020
Oxford Biomedica inks agreement to boost UK supply of AstraZeneca's COVID-19 vaccine
Gene and cell therapy firm Oxford Biomedica said on Monday it signed a new manufacturing agreement to help it scale up production of AstraZeneca's potential COVID-19 vaccine to cater to demand in the United Kingdom and Europe.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment